Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover study

Graboski, Corrie; D. Gray, Shaun; Burnham, Robert

doi:10.1016/j.pain.2005.08.012

Public

Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover study

Published in Pain • Oct 4, 2005

Authors:

Corrie Graboski

Shaun D. Gray

Robert Burnham

Abstract

The treatment of myofascial pain syndrome (MPS) is diverse and includes trigger point injections of various substances including local anesthetics, steroids and Botulinum toxin A (BTX A). The purpose of this study was to compare the effectiveness of trigger point injections using BTX A versus bupiva...

Subject

Medicine

Bupivacaine

Anesthesia

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!